Critical Role of Position 10 Residue in the Polymyxin Antimicrobial Activity
Journal of Medicinal Chemistry · 23.02.2023 · 66 (4) · 2865-2876
DOI: 10.1021/acs.jmedchem.2c01915 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 06.02.2023. Verfasst von Nitin A Patil und 10 weiteren Autor:innen. Beteiligte Einrichtung: Biomedicine Discovery Institute, Infection & Immunity Program and Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia. Hauptthemen laut MEDLINE: Polymyxins, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, National Health and Medical Research Council.
Abstract (Originalsprache)
Polymyxins (polymyxin B and colistin) are lipopeptide antibiotics used as a last-line treatment for life-threatening multidrug-resistant (MDR) Gram-negative bacterial infections. Unfortunately, their clinical use has been affected by dose-limiting toxicity and increasing resistance. Structure-activity (SAR) and structure-toxicity (STR) relationships are paramount for the development of safer polymyxins, albeit very little is known about the role of the conserved position 10 threonine (Thr) residue in the polymyxin core scaffold. Here, we synthesized 30 novel analogues of polymyxin B1 modified explicitly at position 10 and examined the antimicrobial activity against Gram-negative bacteria and in vivo toxicity and performed molecular dynamics simulations with bacterial outer membranes. For the first time, this study revealed the stereochemical requirements and role of the β-hydroxy side chain in promoting the correctly folded conformation of the polymyxin that drives outer membrane penetration and antibacterial activity. These findings provide essential information for developing safer and more efficacious new-generation polymyxin antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biomedicine Discovery Institute, Infection & Immunity Program and Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia.
- National Glycoengineering Research Center, Shandong University, Qingdao 266237, China.
- Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.
ORCID-Profile: Nitin A Patil, Xukai Jiang, Philip E Thompson, Tony Velkov, Jian Li
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Health and Medical Research Council
- Shandong University
Zitieren
APA
Patil, N. A., Ma, W., Jiang, X., He, X., Yu, H. H., Wickremasinghe, H., Wang, J., Thompson, P. E., Velkov, T., Roberts, K. D., & Li, J. (2023). Critical Role of Position 10 Residue in the Polymyxin Antimicrobial Activity. Journal of Medicinal Chemistry, 66(4), 2865-2876. https://doi.org/10.1021/acs.jmedchem.2c01915
Vancouver
Patil NA, Ma W, Jiang X, He X, Yu HH, Wickremasinghe H, et al. Critical Role of Position 10 Residue in the Polymyxin Antimicrobial Activity. Journal of Medicinal Chemistry. 2023;66(4):2865-2876. doi:10.1021/acs.jmedchem.2c01915
BibTeX
@article{Patil2023,
author = {Patil, Nitin A and Ma, Wendong and Jiang, Xukai and He, Xiaoji and Yu, Heidi H and Wickremasinghe, Hasini and Wang, Jiping and Thompson, Philip E and Velkov, Tony and Roberts, Kade D and Li, Jian},
title = {Critical Role of Position 10 Residue in the Polymyxin Antimicrobial Activity},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {4},
pages = {2865--2876},
doi = {10.1021/acs.jmedchem.2c01915}
}
EUVIMED